CLINICAL_TRIALS
trial_result
· 2019-01-11
Clinical Trial Update: A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects [Phase 1]
Summary
A Phase 1 pharmacokinetic study of lurasidone in healthy subjects provides PK data following a single oral dose.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2019-01-11